Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_assertion type Assertion NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_head.
- NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_assertion description "[The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_provenance.
- NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_assertion evidence source_evidence_literature NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_provenance.
- NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_assertion SIO_000772 21397974 NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_provenance.
- NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_assertion wasDerivedFrom befree-20150227 NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_provenance.
- NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_assertion wasGeneratedBy ECO_0000203 NP311889.RAU3s16fg2tehvEfaVV3B5lhBnTx80cXlzZRXKFyL1pYc130_provenance.